Total Payments
$212.24
2024 Payments
$47.08
Companies
10
Transactions
12
Medicare Patients
4,638
Medicare Billing
$648,935
Payment Breakdown by Category
Food & Beverage$186.79 (88.0%)
Education$25.45 (12.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $186.79 | 10 | 88.0% |
| Education | $25.45 | 2 | 12.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $44.12 | 2 | $0 (2021) |
| Medtronic Vascular, Inc. | $27.58 | 2 | $0 (2017) |
| Mylan Specialty L.P. | $24.10 | 1 | $0 (2024) |
| Gilead Sciences, Inc. | $22.98 | 1 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $19.24 | 1 | $0 (2018) |
| Circassia Pharmaceuticals Inc | $18.35 | 1 | $0 (2019) |
| Paratek Pharmaceuticals, Inc. | $15.43 | 1 | $0 (2023) |
| BOSTON SCIENTIFIC CORPORATION | $14.99 | 1 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.89 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $11.56 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47.08 | 2 | Mylan Specialty L.P. ($24.10) |
| 2023 | $15.43 | 1 | Paratek Pharmaceuticals, Inc. ($15.43) |
| 2021 | $44.12 | 2 | AbbVie Inc. ($44.12) |
| 2020 | $11.56 | 1 | AstraZeneca Pharmaceuticals LP ($11.56) |
| 2019 | $18.35 | 1 | Circassia Pharmaceuticals Inc ($18.35) |
| 2018 | $48.12 | 3 | Sunovion Pharmaceuticals Inc. ($19.24) |
| 2017 | $27.58 | 2 | Medtronic Vascular, Inc. ($27.58) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/14/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 05/28/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.98 | General |
| 03/18/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: ANTIBIOTIC | ||||||
| 11/23/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/24/2021 | AbbVie Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/30/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Education | In-kind items and services | $11.56 | General |
| Category: Respiratory | ||||||
| 09/04/2019 | Circassia Pharmaceuticals Inc | TUDORZA PRESSAIR (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: PULMONARYRESPIRATORY DISEASES | ||||||
| 06/06/2018 | BOSTON SCIENTIFIC CORPORATION | GENERAL BRONCHIAL THERMOPLASTY (Device) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: BRONCHIAL THERMOPLASTY | ||||||
| 03/28/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Education | In-kind items and services | $13.89 | General |
| Category: RESPIRATORY | ||||||
| 03/05/2018 | Sunovion Pharmaceuticals Inc. | Utibron (Drug), Seebri, Lonhala Magnair | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Respiratory | ||||||
| 02/23/2017 | Medtronic Vascular, Inc. | Evera (Device) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 02/03/2017 | Medtronic Vascular, Inc. | Evera (Device) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,024 | 1,446 | $583,642 | $138,461 |
| 2022 | 20 | 1,127 | 1,432 | $563,474 | $140,529 |
| 2021 | 23 | 1,190 | 1,624 | $660,659 | $188,229 |
| 2020 | 28 | 1,297 | 1,852 | $688,858 | $181,718 |
Total Patients
4,638
Total Services
6,354
Medicare Billing
$648,935
Procedure Codes
99
All Medicare Procedures & Services
99 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 90 | 212 | $148,188 | $36,485 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 201 | 249 | $97,608 | $24,857 | 25.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 102 | 217 | $73,026 | $20,961 | 28.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 113 | 239 | $54,915 | $15,392 | 28.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 99 | 101 | $64,337 | $13,730 | 21.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 32 | 32 | $13,888 | $3,384 | 24.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $6,834 | $3,375 | 49.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 44 | $12,232 | $3,092 | 25.3% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 93 | 93 | $49,755 | $2,973 | 6.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 17 | $9,367 | $2,520 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $9,880 | $2,053 | 20.8% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 18 | 23 | $8,073 | $2,006 | 24.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $7,414 | $1,816 | 24.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 55 | 55 | $10,505 | $1,666 | 15.9% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 11 | 11 | $4,400 | $1,100 | 25.0% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 12 | 12 | $4,620 | $1,060 | 22.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 13 | 13 | $2,392 | $578.52 | 24.2% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 13 | 13 | $2,249 | $552.72 | 24.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $1,728 | $377.64 | 21.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 26 | 26 | $1,066 | $208.00 | 19.5% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 20 | 20 | $580.00 | $136.99 | 23.6% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 15 | 15 | $585.00 | $135.94 | 23.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 91 | 179 | $125,121 | $32,018 | 25.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 154 | 156 | $99,372 | $25,156 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 164 | 201 | $77,640 | $19,370 | 24.9% |
About Dr. Arvind Bansal, MD
Dr. Arvind Bansal, MD is a Pulmonary Disease healthcare provider based in Fall River, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154408342.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arvind Bansal, MD has received a total of $212.24 in payments from pharmaceutical and medical device companies, with $47.08 received in 2024. These payments were reported across 12 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($186.79).
As a Medicare-enrolled provider, Bansal has provided services to 4,638 Medicare beneficiaries, totaling 6,354 services with total Medicare billing of $648,935. Data is available for 4 years (2020–2023), covering 99 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Sleep Medicine, Critical Care Medicine
- Location Fall River, MA
- Active Since 11/01/2006
- Last Updated 01/22/2025
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1154408342
Products in Payments
- Evera (Device) $27.58
- AVYCAZ (Drug) $26.07
- YUPELRI (Drug) $24.10
- Utibron (Drug) $19.24
- TUDORZA PRESSAIR (Drug) $18.35
- DALVANCE (Drug) $18.05
- NUZYRA (Drug) $15.43
- GENERAL BRONCHIAL THERMOPLASTY (Device) $14.99
- SPIRIVA RESPIMAT (Drug) $13.89
- BREZTRI AEROSPHERE (Drug) $11.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Fall River
Dr. Brendan Carolan, Md, MD
Pulmonary Disease — Payments: $10,587
Pulmonary Disease $10,587
Alejandro Lorenzana, M.d, M.D
Pulmonary Disease — Payments: $8,627
Pulmonary Disease $8,627
Dr. Timur Graham, M.d, M.D
Pulmonary Disease — Payments: $5,469
Pulmonary Disease $5,469
Daniel Sousa, Md, MD
Pulmonary Disease — Payments: $1,596
Pulmonary Disease $1,596
Dr. Lelia Lamp, M.d, M.D
Pulmonary Disease — Payments: $1,059
Pulmonary Disease $1,059
Dr. Nick Mucciardi, Md, MD
Pulmonary Disease — Payments: $973.88
Pulmonary Disease $973.88